Guided Therapeutics (GTHP) Leases (2019 - 2025)
Historic Leases for Guided Therapeutics (GTHP) over the last 7 years, with Q3 2025 value amounting to $69000.0.
- Guided Therapeutics' Leases fell 5792.68% to $69000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $69000.0, marking a year-over-year decrease of 5792.68%. This contributed to the annual value of $141000.0 for FY2024, which is 3788.55% down from last year.
- Latest data reveals that Guided Therapeutics reported Leases of $69000.0 as of Q3 2025, which was down 5792.68% from $94000.0 recorded in Q2 2025.
- In the past 5 years, Guided Therapeutics' Leases registered a high of $426000.0 during Q1 2021, and its lowest value of $69000.0 during Q3 2025.
- Over the past 5 years, Guided Therapeutics' median Leases value was $266000.0 (recorded in 2023), while the average stood at $258368.4.
- In the last 5 years, Guided Therapeutics' Leases skyrocketed by 53606.56% in 2021 and then plummeted by 5792.68% in 2025.
- Guided Therapeutics' Leases (Quarter) stood at $372000.0 in 2021, then decreased by 18.55% to $303000.0 in 2022, then fell by 25.08% to $227000.0 in 2023, then crashed by 37.89% to $141000.0 in 2024, then crashed by 51.06% to $69000.0 in 2025.
- Its Leases was $69000.0 in Q3 2025, compared to $94000.0 in Q2 2025 and $118000.0 in Q1 2025.